Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China flag China · Delayed Price · Currency is CNY
55.95
+4.55 (8.85%)
May 8, 2026, 3:04 PM CST

SHE:300049 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,6171,5871,3421,1471,001891.56
Other Revenue
8.358.357.496.97.376.93
1,6251,5951,3491,1541,009898.48
Revenue Growth (YoY)
19.79%18.26%16.93%14.37%12.27%11.26%
Cost of Revenue
414400.35350.73291.39267.67239.14
Gross Profit
1,2111,195998.28862.34741.09659.34
Selling, General & Admin
677.94675.19584.24527.56474.49405.7
Research & Development
120.55111.299.4982.4770.8264.79
Other Operating Expenses
10.7710.997.8810.4310.7912.5
Operating Expenses
809.18795.48711.39622562.68491.94
Operating Income
401.95399.56286.89240.34178.41167.4
Interest Expense
-3.49-3.22-2.77-0.9-1.58-2.33
Interest & Investment Income
17.6419.2916.0712.389.7310.54
Currency Exchange Gain (Loss)
-32.29-32.2910.37-2.317.9316.48
Other Non Operating Income (Expenses)
14.03-0.48-2.034.08-1.28-0.26
EBT Excluding Unusual Items
397.84382.85308.53253.59193.21191.83
Impairment of Goodwill
-25.59-25.59-7.7---
Gain (Loss) on Sale of Investments
14.816.83-23.11---
Gain (Loss) on Sale of Assets
0.380.38-0.31-0.82-1.86-3.46
Asset Writedown
-6.95-6.95-0-4.71-0-
Legal Settlements
-5.54-5.54----
Other Unusual Items
-11.42-11.42-6.86-12.660.290.77
Pretax Income
363.52350.56270.55235.4191.63189.14
Income Tax Expense
94.6692.1474.6758.2946.2241.1
Earnings From Continuing Operations
268.87258.42195.88177.11145.41148.04
Minority Interest in Earnings
-111.62-104.33-82.59-75.55-47.52-52.57
Net Income
157.25154.09113.29101.5697.8995.47
Net Income to Common
157.25154.09113.29101.5697.8995.47
Net Income Growth
58.51%36.02%11.54%3.75%2.54%54.22%
Shares Outstanding (Basic)
267266263263263260
Shares Outstanding (Diluted)
267266263263263260
Shares Change (YoY)
1.54%0.84%0.15%-0.01%1.30%1.31%
EPS (Basic)
0.590.580.430.390.370.37
EPS (Diluted)
0.590.580.430.390.370.37
EPS Growth
56.10%34.88%11.37%3.76%1.22%52.22%
Free Cash Flow
185.4162.512.44115.6698.69142.94
Free Cash Flow Per Share
0.690.610.010.440.380.55
Dividend Per Share
0.0150.015--0.200-
Gross Margin
74.52%74.91%74.00%74.74%73.47%73.38%
Operating Margin
24.73%25.05%21.27%20.83%17.69%18.63%
Profit Margin
9.68%9.66%8.40%8.80%9.70%10.63%
Free Cash Flow Margin
11.41%10.19%0.18%10.03%9.78%15.91%
EBITDA
482.37478.34359.08307.52236.39221.12
EBITDA Margin
29.68%29.98%26.62%26.65%23.43%24.61%
D&A For EBITDA
80.4378.7872.1967.1857.9853.71
EBIT
401.95399.56286.89240.34178.41167.4
EBIT Margin
24.73%25.05%21.27%20.83%17.69%18.63%
Effective Tax Rate
26.04%26.28%27.60%24.76%24.12%21.73%
Revenue as Reported
1,6251,5951,3491,1541,009898.48
Advertising Expenses
-3.133.344.769.839.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.